Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Harrington

Showing results (61-70 of 197) with videos related to

Pageof 20
Sort By:
Cancer Treatment Reviews|January 14, 2023
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neckRobert L Ferris, Kevin Harrington, Jonathan D Schoenfeld, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literatureRita Simões, Yolanda Augustin, Sarah Gulliford, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Taste dysfunction following radiotherapy to the head and neck: A systematic reviewLucinda Gunn, James Gilbert, Pablo Nenclares, et al.
The British Journal of Radiology|May 22, 2020
The impact of restricted length of treatment field and anthropometric factors on selection of head and neck cancer patients for treatment on the MR-LinacBrian Ng-Cheng-Hin, Christopher Nutting, Kate Newbold, et al.
Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.
IEEE Transactions on Bio-Medical Engineering|November 7, 2014
Robotic system for MRI-guided stereotactic neurosurgeryGang Li, Hao Su, Gregory A Cole, et al.
Technical Innovations & Patient Support in Radiation Oncology|August 1, 2025
Patient experience of head and neck treatment on a 1.5 T MR-Linac: is the ATS-lite adaptive solution tolerable?Helen Barnes, Sophie Alexander, Shreerang Bhide, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2008
Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancerRehan Kazi, Ramachandran Venkitaraman, Catherine Johnson, et al.
Cancer Treatment Reviews|July 1, 2023
Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?Robert I Haddad, Kevin Harrington, Makoto Tahara, et al.
Pageof 20

Showing results (61-70 of 197) with videos related to

Sort By:
Pageof 20
Cancer Treatment Reviews|January 14, 2023
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neckRobert L Ferris, Kevin Harrington, Jonathan D Schoenfeld, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literatureRita Simões, Yolanda Augustin, Sarah Gulliford, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2021
Taste dysfunction following radiotherapy to the head and neck: A systematic reviewLucinda Gunn, James Gilbert, Pablo Nenclares, et al.
The British Journal of Radiology|May 22, 2020
The impact of restricted length of treatment field and anthropometric factors on selection of head and neck cancer patients for treatment on the MR-LinacBrian Ng-Cheng-Hin, Christopher Nutting, Kate Newbold, et al.
Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.
IEEE Transactions on Bio-Medical Engineering|November 7, 2014
Robotic system for MRI-guided stereotactic neurosurgeryGang Li, Hao Su, Gregory A Cole, et al.
Technical Innovations & Patient Support in Radiation Oncology|August 1, 2025
Patient experience of head and neck treatment on a 1.5 T MR-Linac: is the ATS-lite adaptive solution tolerable?Helen Barnes, Sophie Alexander, Shreerang Bhide, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2008
Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancerRehan Kazi, Ramachandran Venkitaraman, Catherine Johnson, et al.
Cancer Treatment Reviews|July 1, 2023
Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?Robert I Haddad, Kevin Harrington, Makoto Tahara, et al.
Pageof 20